Focus Product Scheme benefit applies to exports of finished dosage forms containing omeprazole or lansoprazole, treated separately. Regional authorities are directed to grant Focus Product Scheme incentives for exports of finished dosage forms that use either Omeprazole or Lansoprazole as the active pharmaceutical ingredient, the Department of Pharmaceuticals having clarified the tariff entry covers the two distinct finished-dosage-form products rather than a combined formulated product.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Focus Product Scheme benefit applies to exports of finished dosage forms containing omeprazole or lansoprazole, treated separately.
Regional authorities are directed to grant Focus Product Scheme incentives for exports of finished dosage forms that use either Omeprazole or Lansoprazole as the active pharmaceutical ingredient, the Department of Pharmaceuticals having clarified the tariff entry covers the two distinct finished-dosage-form products rather than a combined formulated product.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
